5-Acetyl-4-(3-hydroxyphenyl)-6-methyl-1,2,3,4-tetrahydropyrimidin-2-one–tris(hydroxymethyl)ammonium chloride (2/1)
The asymmetric unit of the title compound, 2C13H14N2O3·C3H10NO3+·Cl−, contains two independent molecules (AandB) of the title pyrimidine derivative and one ion-pair of tris(hydroxymethyl)ammonium chloride. The pyrimidine ring in each pyrimidine derivative has a half-chair conformation. Its mean plane is inclined to the benzene ring by 87.2 (3)° in moleculeAand 85.7 (2)° in moleculeB. In the crystal, the pyrimidine derivatives are connected to each other by N—H...O hydrogen bonds, forming chains propagating along theb-axis direction. The chains are linkedviaO—H—Cl hydrogen bonds, forming corrugated sheets lying parallel to thebcplane. The sheets are linkedviaC—H...O hydrogen bonds, forming a three-dimensional framework. The tris(hydroxymethyl)ammonium chloride molecules are located in the cages of the framework. There are also further C—H...O hydrogen bonds and C—H...π interactions present in the three-dimensional framework structure. Both the cation and chloride anion of the tris(hydroxymethyl)ammonium chloride ion pair are disordered over two positions, with a refined occupancy ratio of 0.418 (8):0.582 (8) for the cation and 0.71 (4):0.29 (4) for the anion.